Ciclotizolam
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
8-bromo-6-(o-chlorophenyl)-1-cyclohexyl-4H-5-triazolo(3,4-c)thieno(2,4-e)-1,4-diazepine | |
Identifiers | |
CAS Number |
58765-21-2 ![]() |
ATC code | none |
PubChem | CID 71949 |
ChemSpider |
64956 ![]() |
UNII |
JK517QTN4Q ![]() |
ChEMBL |
CHEMBL2105986 ![]() |
Chemical data | |
Formula | C20H18BrClN4S |
Molar mass | 461.806 g/mol |
| |
| |
![]() ![]() |
Ciclotizolam[1] (WE-973) is a drug which is a thienotriazolodiazepine derivative. It is a partial agonist for the benzodiazepine site of the GABAA receptor, with similar binding affinity to related compounds like brotizolam, but a low efficacy.[2][3]
See also
References
- ↑ DE Patent 2445430
- ↑ Weber KH, Kuhn FJ, Böke-Kuhn K, Lehr E, Danneberg PB, Hommer D, Paul SM, Skolnick P (February 1985). "Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines')". European Journal of Pharmacology 109 (1): 19–31. doi:10.1016/0014-2999(85)90535-7. PMID 2986988.
- ↑ Ikeda M, Weber KH, Bechtel WD, Malatynska E, Yamamura HI (1989). "Relative efficacies of 1,4-diazepines on GABA-stimulated chloride influx in rat brain vesicles". Life Sciences 45 (4): 349–58. doi:10.1016/0024-3205(89)90145-8. PMID 2569655.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.